The human antibody response to dengue virus infection.

Viruses
Wahala M P B Wahala, Aravinda M de Silva

Abstract

Dengue viruses (DENV) are the causative agents of dengue fever (DF) and dengue hemorrhagic fever (DHF). Here we review the current state of knowledge about the human antibody response to dengue and identify important knowledge gaps. A large body of work has demonstrated that antibodies can neutralize or enhance DENV infection. Investigators have mainly used mouse monoclonal antibodies (MAbs) to study interactions between DENV and antibodies. These studies indicate that antibody neutralization of DENVs is a "multi-hit" phenomenon that requires the binding of multiple antibodies to neutralize a virion. The most potently neutralizing mouse MAbs bind to surface exposed epitopes on domain III of the dengue envelope (E) protein. One challenge facing the dengue field now is to extend these studies with mouse MAbs to better understand the human antibody response. The human antibody response is complex as it involves a polyclonal response to primary and secondary infections with 4 different DENV serotypes. Here we review studies conducted with immune sera and MAbs isolated from people exposed to dengue infections. Most dengue-specific antibodies in human immune sera are weakly neutralizing and bind to multiple DENV serotypes. The human ...Continue Reading

Associated Clinical Trials

References

May 1, 1991·The American Journal of Tropical Medicine and Hygiene·V ChurdboonchartS Sirinavin
Apr 1, 1989·The American Journal of Tropical Medicine and Hygiene·S C KliksD S Burke
Nov 1, 1989·The American Journal of Tropical Medicine and Hygiene·B M KaufmanK H Eckels
Mar 1, 1988·The American Journal of Tropical Medicine and Hygiene·S C KliksD S Burke
Jan 1, 1983·The American Journal of Tropical Medicine and Hygiene·S B HalsteadN Sangkawibha
Sep 6, 2000·Clinical and Diagnostic Laboratory Immunology·K ValdésM G Guzmán
May 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yorgo ModisStephen C Harrison
Dec 24, 2003·Advances in Virus Research·Alan L Rothman
Dec 24, 2003·Advances in Virus Research·Scott B Halstead
Dec 31, 2003·Advances in Virus Research·John T Roehrig
Dec 31, 2003·Advances in Virus Research·Rebeca Rico-Hesse
Sep 3, 2004·Structure·Ying ZhangMichael G Rossmann
Dec 21, 2004·Nature Reviews. Microbiology·Suchetana MukhopadhyayMichael G Rossmann
Dec 23, 2004·Journal of Virology·Yorgo ModisStephen C Harrison
May 4, 2005·Virology·Melissa D SánchezRobert W Doms
Jul 5, 2006·Viral Immunology·Chiou-Feng LinYee-Shin Lin
Aug 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Bärbel KaufmannMichael G Rossmann
Sep 22, 2006·Journal of Virology·Grant E NybakkenDaved H Fremont
May 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ana P GoncalvezChing-Juh Lai
Aug 3, 2007·Journal of Virology·Karin StiasnyFranz X Heinz
Aug 24, 2007·Journal of Virology·Theodore OliphantMichael S Diamond
Nov 13, 2007·Lancet·Scott B Halstead
Dec 27, 2007·Viral Immunology·Allison ImriePaul Effler
Feb 12, 2008·Nature Structural & Molecular Biology·Shee-Mei LokMichael G Rossmann
Feb 19, 2008·Vector Borne and Zoonotic Diseases·L Lazaro-OlánL Cedillo-Barrón
May 13, 2008·Expert Reviews in Molecular Medicine·Theodore C Pierson, Michael S Diamond

❮ Previous
Next ❯

Citations

Apr 10, 2013·Proceedings of the National Academy of Sciences of the United States of America·Kannan TharakaramanRam Sasisekharan
Jun 14, 2013·Journal of Biomedical Science·Shu-Wen WanYee-Shin Lin
Oct 1, 2013·BMC Evolutionary Biology·Boon-Teong TeohSazaly AbuBakar
Jun 4, 2013·BMC Infectious Diseases·Angela F L T ArgoloCelina M T Martelli
Jan 5, 2014·PLoS Neglected Tropical Diseases·Petra EmmerichHerbert Schmitz
Jul 3, 2013·PLoS Pathogens·Oksana VratskikhFranz X Heinz
Nov 10, 2013·PLoS Pathogens·Raphaël M ZellwegerSujan Shresta
May 1, 2013·Future Virology·James S Testa, Ramila Philip
Feb 7, 2014·Proceedings of the National Academy of Sciences of the United States of America·Falk Nimmerjahn, Anja Lux
Nov 3, 2014·Annual Review of Virology·Theodore C Pierson, Michael S Diamond
Jan 5, 2014·Journal of Mathematical Biology·Tanvi P Gujarati, G Ambika
Jan 1, 2014·Vaccines·Weidang LiAshlesh K Murthy
Aug 30, 2013·Expert Review of Vaccines·Monica A McArthurRobert Edelman
Mar 5, 2016·Genome Biology·Shuzhen Sim, Martin L Hibberd
Mar 1, 2016·Reviews in Medical Virology·Marycelin BabaDaniel K Masiga
Nov 11, 2015·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Tomohiro KotakiEiji Konishi
Nov 3, 2015·Antiviral Research·Ririn RamadhanyTakeshi Kurosu
Nov 22, 2015·Indian Journal of Pediatrics·Rakesh Lodha, Sushil K Kabra
Nov 26, 2015·Future Microbiology·Candice Y Y Chan, Eng Eong Ooi
Aug 6, 2013·International Journal of Clinical Practice·R A Stein
Jun 21, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Bei ZhangPatrick Hunziker
Aug 13, 2013·BioMed Research International·Rosmari Rodriguez-Roche, Ernest A Gould
Sep 16, 2014·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Tomohiro KotakiEiji Konishi
Mar 25, 2015·The Journal of Infectious Diseases·Monica A McArthur, Robert Edelman
Mar 18, 2016·The Journal of Infectious Diseases·Brett M ForsheyAmy C Morrison
Sep 25, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·F X Heinz, Karin Stiasny
Oct 14, 2014·Frontiers in Immunology·Carlos A Sariol, Laura J White
Dec 31, 2014·Virologica Sinica·Jianchun WeiJing An
Jul 29, 2015·PLoS Neglected Tropical Diseases·Monica PoggianellaOscar R Burrone
May 5, 2016·Infectious Diseases of Poverty·Jian-Peng XiaoYong-Hui Zhang
Apr 9, 2016·The Journal of Infectious Diseases·Priscila M S CastanhaErnesto T A Marques
Oct 21, 2014·PLoS Neglected Tropical Diseases·Darunee BuddhariIn-Kyu Yoon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.